Effects of Belimumab (BEL) on Renal Outcomes in Patients (pts) with Relapsed and Newly Diagnosed Active Lupus Nephritis (LN)

被引：0
|
作者：
Anders, Hans J. [1 ]
Rovin, Brad H. [2 ]
Zhao, Ming Hui [3 ]
Malvar, Ana [4 ]
Hiromura, Keiju [5 ]
Jones-Leone, Angela R. [6 ]
Gonzalez-Rivera, Tania [6 ]
Gilbride, Jennifer A. [7 ]
Madan, Anuradha [6 ]
Green, Yulia [8 ]
Roth, David A. [6 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany
[2] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA
[3] Peking Univ First Hosp, Beijing, Peoples R China
[4] Org Med Invest, Buenos Aires, DF, Argentina
[5] Gunma Univ, Grad Sch Med, Dept Nephrol & Rheumatol, Maebashi, Gumma, Japan
[6] GlaxoSmithKline, Collegeville, PA USA
[7] GlaxoSmithKline, Stevenage, Herts, England
[8] GlaxoSmithKline, Brentford, England
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-OR32
引用
收藏
页码：48 / 49
页数：2
相关论文
共 50 条
  • [21] Health Outcomes Among Patients (Pts) with SLE Initiating Belimumab (BEL) with and Without the Use of Immunosuppressants in the Previous 2 Years
    Chen, Yan
    Worley, Karen
    Rabideau, Brendan
    Rubin, Bernard
    Wu, Benson
    Chang, Rose
    DerSarkissian, Maral
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4661 - 4663
  • [22] Newly Diagnosed Lupus Nephritis in Elderly Predicts Good Renal Outcome: A Distinct Disease Subset from Young-onset Lupus Nephritis
    Hiramoto, Kazuoto
    Hanaoka, Hironari
    Kikuchi, Jun
    Saito, Shuntaro
    Takei, Hiroshi
    Oshige, Tatsuhiro
    Seki, Noriyasu
    Tsujimoto, Hideto
    Kaneko, Yuko
    Takeuchi, Tsutomu
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [23] Efficacy of initial combination with belimumab in newly diagnosed childhood-onset lupus nephritis: a single-centre historical control study
    Gong, Yinv
    Liu, Shuhua
    Liu, Haimei
    Shi, Yu
    Li, Yifan
    Guan, Wanzhen
    Zeng, Qiaoqian
    Lv, Qianying
    Zhang, Xiaomei
    Wei, Qijiao
    Chen, Jing
    Shen, Qian
    Xu, Hong
    Sun, Li
    LUPUS SCIENCE & MEDICINE, 2024, 11 (02):
  • [24] Clinical pharmacology considerations for the approval of belimumab for the treatment of adult patients with active lupus nephritis: A regulatory perspective
    Liu, Tao
    Neuner, Rosemarie
    Thompson, Aliza
    Pottackal, Ginto
    Petullo, David
    Liu, Jiang
    Nikolov, Nikolay
    Sahajwalla, Chandrahas
    Doddapaneni, Suresh
    Chen, Jianmeng
    LUPUS, 2022, 31 (04) : 424 - 432
  • [25] Belimumab Improves Renal Responses in Patients with or Without Steroid Pulses During Induction Therapy for Lupus Nephritis
    Furie, Richard
    Houssiau, Frederic
    Lightstone, Liz
    Yu, Xueqing
    Weinmann-Menke, Julia
    Tanaka, Yoshiya
    Jones-Leone, Angela
    Gonzalez-Rivera, Tania
    Gilbride, Jennifer
    Madan, Anuradha
    Green, Yulia
    Roth, David
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3068 - 3070
  • [26] Good pregnancy outcomes in lupus nephritis patients with complete renal remission
    Chen, Yinghua
    Li, Kang
    Zhang, Haitao
    Liu, Zhengzhao
    Chen, Duqun
    Yang, Liu
    Hu, Weixin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (10) : 1888 - 1894
  • [27] EFFICACY AND SAFETY OF BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS: A PHASE 3, RANDOMISED, PLACEBO-CONTROLLED TRIAL
    Rovin, Brad
    Houssiau, Frederic A.
    Furie, Richard
    Malvar, Ana
    Teng, Y. K. O.
    Mok, Chi Chiu
    Contreras, Gabriel
    Yu, Xueqing
    Dolff, Sebastian
    Ji, Beulah
    Roth, David
    Kleoudis, Christi
    Bass, Damon
    Madan, Anuradha
    Wright, Amanda
    Barnett, Carly
    Green, Yulia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 2181 - 2182
  • [28] Renal biopsy complications in patients diagnosed with Lupus Nephritis - experience of a Portuguese Rheumatology Center
    Agueda, A.
    Farinha, F.
    Cunha, I.
    Barcelos, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (03) : S80 - S80
  • [29] Effect of Belimumab Treatment on Renal Outcomes: Results From Phase 3 Belimumab Clinical Trials in Patients with Systemic Lupus Erythematosus
    Dooley, M. A.
    Houssiau, F.
    Aranow, C.
    D'Cruz, D. P.
    Askanase, Anca D.
    Roth, D.
    Zhong, Z. J.
    Freimuth, W.
    Ginzler, E. M.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S963 - S964
  • [30] Upregulation of renal and systemic cyclooxygenase-2 in patients with active lupus nephritis
    Tomasoni, S
    Noris, M
    Zappella, S
    Gotti, E
    Casiraghi, F
    Bonazzola, S
    Benigni, A
    Remuzzi, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1998, 9 (07): : 1202 - 1212
12345